Bio Dalane AS
ASActiveOrg 991319786Sjukehusveien 20, 4373 EgersundSteam and air conditioning supply· NACE 3530Est. 2007 · 19 years old0 employeeshttps://www.biodalane.no
Loading company…
Overview
Bio Dalane AS is a Norwegian AS based in Egersund, operating in the Steam and air conditioning supply sector. Incorporated in 2007, the company has 0 employees and reported revenue of NOK 3.2m in its latest annual filing.
Revenue 2025
3.2M NOK
+6% vs 2024
EBITDA margin
27.7 %
+13% vs 2024
Net profit 2025
0.2M NOK
+52% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
79.0 %
StrongAmong the 30% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
2.6×
StrongAmong the 40% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
4.5 %
StrongAmong the 30% highest rated companies in the industry
20212025
EBITDA — year on year
NOK thousandsKey figures
Annual report 2025| Revenue | 3.2M NOK | +6% |
| EBITDA | 0.9M NOK | +13% |
| Net profit | 0.2M NOK | +52% |
| Total assets | 5.5M NOK | -6% |
| Equity | 4.4M NOK | -6% |
| Employees | 0 | — |
Company information
Legal name
BIO DALANE AS
Org number
991319786
Legal form
Aksjeselskap
NACE code
Founded
19 March 2007 · 19 years
Share capital
NOK 4,368,000
Employees
0 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og nestleder hver for seg.
Company purpose
Energi/varmeleveranse basert på bioenergi inn mot offentlige og private bygg, og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
(no translation available)
Contact
Address
Sjukehusveien 20, 4373 Egersund
Website
https://www.biodalane.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Bio Dalane AS reported revenue of NOK 3.2m, an increase of 6% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 248.4k, and the EBITDA margin stood at 27.7%.
At the end of 2025, equity financed 79% of the balance sheet, and current assets covered short-term debt 2.6 times.
Financials
Revenue
NOK thousandsEBITDA
NOK thousandsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3,242 | 3,064 | 3,274 | 4,251 | 3,146 |
| Staff expenses | -55 | -61 | -57 | -57 | -66 |
| EBITDA | 898 | 797 | 1,520 | 1,435 | 866 |
| Depreciation & amort. | -603 | -596 | -579 | -560 | -560 |
| EBIT | 295 | 201 | 941 | 875 | 306 |
| Net financials | 23 | 9 | 1 | -21 | -62 |
| Profit before tax | 319 | 210 | 941 | 855 | 244 |
| Tax | 70 | 47 | 208 | 188 | 54 |
| Net profit | 248 | 163 | 734 | 667 | 190 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 5,527 | 5,911 | 6,376 | 6,798 | 6,694 |
| Equity | 4,369 | 4,667 | 4,941 | 4,731 | 4,501 |
| Long-term debt | 137 | 174 | 200 | 253 | 1,452 |
| Short-term debt | 1,022 | 1,070 | 1,235 | 1,814 | 741 |
| Total debt | 1,159 | 1,244 | 1,435 | 2,067 | 2,193 |
Financial ratios
5-year trendEBITDA margin
27.7 %
20212025
Equity ratio
79.0 %
StrongAmong the 30% highest rated companies in the industry
20212025
Return on equity
5.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Net profit margin
7.7 %
AverageAround the average of companies in the same industry
20212025
Asset turnover
0.59×
Very strongAmong the 20% highest rated companies in the industry
20212025
Debt / equity
0.27×
StrongAmong the 30% highest rated companies in the industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 20% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginAverage
Around the average of companies in the same industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginAverage
Around the average of companies in the same industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Strong
Among the 40% highest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Strong
Among the 30% highest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Strong
Among the 40% highest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Strong
Among the 30% highest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioStrong
Among the 40% highest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 40% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioAverage
Around the average of companies in the same industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioStrong
Among the 40% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityAverage
Around the average of companies in the same industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalStrong
Among the 30% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery strong
Among the 10% highest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 30% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 30% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityStrong
Among the 30% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 30% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery strong
Among the 20% highest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery strong
Among the 10% highest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery strong
Among the 10% highest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtStrong
Among the 30% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginStrong
Among the 30% highest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverVery strong
Among the 20% highest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverVery strong
Among the 10% highest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalWeak
Among the 40% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SB Deputy Member | Deputy Member | 2026 |
BH Chief Executive Officer | Chief Executive Officer | 2022 |
Former (3)
OJ Deputy Member | Deputy Member | 2020 – 2022 |
SP Deputy Member | Deputy Member | 2022 – 2026 |
IH Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
TH Board of Directors | Board of Directors | 2022 |
JE Board of Directors | Board of Directors | 2026 |
IA Board of Directors | Board of Directors | 2026 |
PS Board of Directors | Board of Directors | 2025 |
GS Chairman | Chairman | 2025 |
Former (4)
OJ Chairman | Chairman | 2022 – 2025 |
MS Board of Directors | Board of Directors | 2024 – 2026 |
JT Board of Directors | Board of Directors | 2022 – 2022 |
AE Chairman | Chairman | 2020 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 33.97% | 33.97% | 2020 | |
| Individual | 19.57% | 19.57% | 2024 | |
| Individual | 10.6% | 10.6% | 2024 | |
| Individual | 5.31% | 5.31% | 2024 | |
| Company | 4.58% | 4.58% | 2020 | |
| Individual | 1.83% | 1.83% | 2020 | |
| Individual | 1.6% | 1.6% | 2025 | |
| Individual | 1.37% | 1.37% | 2020 | |
| Company | 1.14% | 1.14% | 2020 | |
| Individual | 1.14% | 1.14% | 2020 | |
| Company | 1.14% | 1.14% | 2020 | |
| Individual | 0.76% | 0.76% | 2024 | |
| Individual | 1.6% | 1.6% | 2020 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Green Bio Sør As
Bio Dalane AS Board network connections
Board members of Bio Dalane AS also hold positions in 98 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Skjevrak | Chairman | 34 companiesMany roles |
| Jan Tore Klemmetsen | Board of Directors | 22 companiesMany roles |
| Ottar Jone Rusdal | Deputy Member | 15 companiesMany roles |
| Børge Helland | Chief Executive Officer | 10 companiesMany roles |
| Arne Eiken | Chairman | 9 companiesMany roles |
| Trygve Håland | Board of Directors | 3 companies |
| Stein Pettersen | Deputy Member | 1 company |
| Sverre Bernhard Ørsland | Deputy Member | 1 company |
| Ivar Hetland | Chief Executive Officer | 1 company |
| Johan Egeland | Board of Directors | 1 company |
| Ivar Are Veen | Board of Directors | 1 company |
Frequently asked questions
What is the Org number of Bio Dalane AS?
Bio Dalane AS is registered with Brønnøysundsregistrene under Org 991319786.
What is the revenue of Bio Dalane AS?
Bio Dalane AS reported revenue of NOK 3.2m in 2025.
Who is the CEO of Bio Dalane AS?
Børge Helland is the CEO of Bio Dalane AS, in role since 2022.
Who is the chairman of Bio Dalane AS?
Geir Skjevrak chairs the board of Bio Dalane AS, in role since 2025.
Where is Bio Dalane AS headquartered?
Bio Dalane AS's registered address is Sjukehusveien 20.